Zobrazeno 1 - 10
of 16
pro vyhledávání: '"S. G Bagrova"'
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 120-124 (2019)
Anaplastic lymphoma kinase (ALK) translocation is a rare genetic disorder that underlies lung cancer development. As a rule, these are young people, people with no or little smoking experience in whom the diagnosis is made at a late stage of the dise
Externí odkaz:
https://doaj.org/article/77054dd3d7e045668291e1777d3084ef
Autor:
N. S. Besova, T. A. Titova, S. G. Bagrova, E. S. Obarevich, V. A. Gorbunova, E. V. Artamonova
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 120-127 (2019)
Gastric cancer (GC) is one of the most common types of malignant tumour worldwide and is ranked fifth in the cancer incidence pattern and third in the cancer mortality pattern. In the Russian Federation, 39.9% of patients are diagnosed with stage IV
Externí odkaz:
https://doaj.org/article/ab47b0e65013444fb871bd435e2ade6f
Autor:
N. S. Besova, T. A. Titova, D. L. Stroyakovsky, E. V. Perminova, S. G. Bagrova, E. S. Obarevich, V. A. Gorbunova, E. V. Artamonova, I. S. Stilidi
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 100-109 (2019)
Background: Several studies show that the combination chemotherapy with ramucirumab allows to improve the treatment results of advanced gastric cancer (GC). Irinotecan with fluoropyrimidines is own of the second line chemotherapy options for these pa
Externí odkaz:
https://doaj.org/article/ea3ef83961b9437bae7fe589b286537d
Publikováno v:
Современная онкология, Vol 20, Iss 3, Pp 5-9 (2018)
Introduction. Patients with advanced small cell lung cancer (SCLC) have an extremely poor prognosis on the background of standard chemotherapy combination of etoposide and platinum-based drugs. In a randomized, double-blind of СА184-156 phase III s
Externí odkaz:
https://doaj.org/article/70bacb626d7349df8314bc1704807dc4
Autor:
T. D. Barbolina, S. G. Bagrova
Publikováno v:
Medical alphabet. :27-30
For a long time, cytostatic therapy practically does not increase life expectancy than up to 18 months. The article describes the latest advances in the development of drug treatment of pleural mesothelioma and the results of the CheckMate‑743 tria
Autor:
E. V. Evdokimova, E. V. Artamonova, V. V. Delectorskaya, G. Yu. Chemeris, G. S. Emelyanova, S. G. Bagrova, A. A. Markovich
Publikováno v:
Medical alphabet. :20-24
Considering the fact that the group of neuroendocrine carcinomas (NECs) grade 3 is heterogenous, in the year of 2017 a new subgroup of welldifferentiated neuroendocrine tumors grade 3 (NETs G3) was described. NETs G3 are tumors with more favorable pr
Autor:
S. G. Bagrova, A. V. Egorova, V. I. Kuzmina, E. V. Artamonova, Ya. A. Zhulikov, D. A. Denchik, V. A. Haylenko, E. I. Kovalenko, E. K. Shoua, T. N. Zabotina, Z.G. Kadagidze, M. V. Kiselevsky, I. K. Vorotnikov, E. N. Zakharova, M. V. Khoroshilov
Publikováno v:
Medical alphabet. :32-37
Tumor-infiltrating lymphocytes (TILs) play a key role in the formation of anti-tumor immunity and, as studies have shown, can be one of the markers of treatment effectiveness and cancer prognosis. The aim was to study the subpopulation composition of
Autor:
S. G. Bagrova, A. A. Kolomeytseva, N. S. Besova, А. A. Markovich, V. A. Gorbunova, E. V. Artamonova, N. V. Lyubimova, G. S. Emelyanova, Е. I. Kovalenko
Publikováno v:
Medical alphabet. :38-41
Advanced well differentiated neuroendocrine tumors (NET) have poor sensitivity to chemotherapy. Approaches to the second and subsequent lines of treatment have not been developed to date Aranosa is a derivative of nitrosourea. it is close to streptoz
Autor:
S. G. Bagrova, N. S. Besova, E. I. Kovalenko, E. V. Artamonova, A. A. Markovich, G. S. Emelyanova, N. V. Lyubimova, V. A. Gorbunova
Publikováno v:
Medical alphabet. :19-24
Background. The diagnostics of neuroendocrine tumors (NET) is complex due to many factors such as the heterogeneity of the tumors themselves, different localization of the tumor process, and the presence of severe hormonal syndromes. A special place
Autor:
E V Poddubskaya, M P Baranova, Konstantin Laktionov, S. G Bagrova, A E Kuzminov, Vera Gorbunova
Publikováno v:
Современная онкология, Vol 20, Iss 3, Pp 5-9 (2018)
Introduction. Patients with advanced small cell lung cancer (SCLC) have an extremely poor prognosis on the background of standard chemotherapy combination of etoposide and platinum-based drugs. In a randomized, double-blind of СА184-156 phase III s